A053030 Share Price Performance
₩6,400.00
-9850.00 (-60.62%)
71.6% undervalued intrinsic discount
₩22,568.77
Fair Value
Price ₩6,400.00
AnimalDoctorKwon ₩22,568.77
Fair Value₩22,568.77
Share Pricen/a
New Narrative • Jul 20
BINEX Co., Ltd. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
A053030 Community Narratives
AN
Fair Value
·Fair Value ₩22.57k 71.6% undervalued intrinsic discount
Binex pivot to a global bio-CDMO requires more than Biosecure Act tailwinds; it demands a total cultural evolution from its 2021 compliance
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Binex pivot to a global bio-CDMO requires more than Biosecure Act tailwinds; it demands a total cultural evolution from its 2021 compliance
Binex wants to shift from a generic drug maker into a global partner for complex biologic medicines, but a repeat history of rule-breaking raises a bigger question: can the company truly change how it operates. The stock looks cheap for reasons that go beyond industry tailwinds, and the next few years hinge on whether management can rebuild trust with regulators and large drugmakers.Read more
AN
₩22.57k
71.6% undervalued intrinsic discount
Fair Value
Profit Margin
14.63%
Future PE
21x
Price in 2031
₩31.71k
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
Binex pivot to a global bio-CDMO requires more than Biosecure Act tailwinds; it demands a total cultural evolution from its 2021 compliance
Fair Value: ₩22.57k 71.6% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
BINEX Co., Ltd. Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
- -403.67
- 22.42%
- -7.84%
- 56.4%
About A053030
- Founded
- 1957
- Employees
- 667
- CEO
- WebsiteView website
BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company engages in cell line and process development, and analytical method production development. It is also involved in cell cultivation and microbial fermentation modalities process production. In addition, the company offers chemical pharmaceutical products. BINEX Co., Ltd. was founded in 1957 and is headquartered in Busan, South Korea.
